Search for: "Eli Lilly " Results 261 - 280 of 2,147
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jan 2008, 4:50 pm
The New York Times reported today that Eli Lilly is discussing the possibility of settling civil and criminal investigations... [read post]
27 Dec 2006, 5:20 am
In a follow up to a recent post about Eli Lilly's techniques of "playing down" the health risks associated with its Zyprexa drug, it appears that Eli Lilly also promoted unapproved use of the drug to physicians. [read post]
28 Feb 2013, 6:01 am
This suit, filed by patent attorneys for Eli Lilly & Company ("Lilly") and its subsidiary ImClone Systems LLC, of Delaware, included as defendants both Genentech, Inc. [read post]
10 Oct 2017, 7:30 am by Steve Brachmann
On Thursday, October 5th, a final written decision issued by the Patent Trial and Appeal Board (PTAB) upheld a series of 22 claims from a patent owned by Indianapolis, IN-based drugmaker Eli Lilly & Company (NYSE:LLY). [read post]
24 Feb 2009, 9:43 pm
Seeking approval to manufacture and market a generic version of Plaintiff-Appellee Eli Lilly and Company's raloxifene hydrochloride formulation, which Lilly markets as Evista ® for the treatment and prevention of postmenopausal osteoporosis, Teva filed an ANDA with the FDA in 2006. [read post]
29 Nov 2021, 1:55 pm by Tom Lamb
As background, Xeljanz is a Pfizer drug, Rinvoq is an AbbVie drug, and Olumiant is an Eli Lilly drug. [read post]
2 Apr 2015, 7:51 am by Robert Kraft
” The Wall Street Journal added that Eli Lilly gained the rights to Cyramza when it acquired ImClone Systems in 2008. [read post]
9 Jan 2013, 11:25 am
Eli Lilly settles Mass. pregnancy drug-cancer case, www.miamiherald.com January 09, 2013 [read post]
15 Jun 2009, 7:20 pm
Eli Lilly marketed the antipsychotic drug Zyprexa for off-label use despite knowledge that was not effective, Bloomberg News reports. [read post]
17 Mar 2008, 5:09 pm
Eli Lilly E-Mail Discussed Unapproved Use of Drug”, The New York [...] [read post]
28 Oct 2013, 1:12 pm by Justin K. Beyer
  On August 14, 2013, a grand jury in the Southern District of Indiana returned a superseding indictment against Guoqing Cao (“Cao”) and Shuyu “Dan” Li (“Li”), stemming from Cao and Li’s alleged multi-year plot to steal Eli Lilly trade secrets and transfer those secrets to one of Eli Lilly’s Chinese-based competitors, Jiangsu Hengrui Medicine Co., Ltd., located in Shanghai, China. [read post]
19 Aug 2010, 6:20 pm by Lawrence B. Ebert
Shelley DuBois begins a piece on patent problems at Eli Lilly with the paragraph:In 2009, Eli Lilly CEO John Lechleiter introduced a new drug development strategy called the Development Center of Excellence. [read post]
11 Jan 2013, 4:04 pm
Boston lawsuit claims DES-breast cancer link, USA Today, January 10, 2012 Eli Lilly Settles Mass. [read post]
7 Feb 2008, 5:08 am
The Eli Lilly settlement-talks story just got weirder. [read post]
1 Mar 2016, 10:06 am
Indianapolis, Indiana - An Indiana patent attorney for Plaintiff Eli Lilly & Company ("Lilly") of Indianapolis, Indiana filed a lawsuit in the Southern District of Indiana alleging that Biocon Limited of Bangalore, India will infringe its patented chemotherapy drug, which Lilly offers under the brand name ALIMTA. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  The jury found that Takeda was 75% liable and Eli Lilly was 25% liable, and split the punitive award accordingly – $6 billion against Takeda and $3 billion against Lilly. [read post]